STAT3: A multifaceted oncogene

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 27, 2006, Pages 10151-10152

  Levy, David E ^a   Inghirami, Giorgio ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; CD4 ANTIGEN; CYTOKINE; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; NUCLEOPLASMIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TYROSINE;

APOPTOSIS; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; ENHANCER REGION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MODIFICATION; ENZYME PHOSPHORYLATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; NOTE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR GROWTH;

HUMANS; NEOPLASMS; ONCOGENE PROTEINS; STAT3 TRANSCRIPTION FACTOR;

EID: 33745905938     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0604042103     Document Type: Note

References (14)

1. Levy, D. E. & Darnell, J. E., Jr. (2002) Nat. Rev. Mol. Cell. Biol. 3, 651-662.
2. Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J. & Jove, R. (1995) Science 269, 81-83.
3. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C. & Darnell, J. E., Jr. (1999) Cell 98, 295-303.
4. Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E. & Stark, G. R. (2005) Cancer Res. 65, 939-947.
5. Kasprzycka, M., Marzec, M., Liu, X., Zhang, Q. & Wasik, M. A. (2006) Proc. Natl. Acad. Sci. USA 103, 9964-9969.
6. O'Garra, A. & Vieira, P. (2004) Nat. Med. 10, 801-805.
7. Inghirami, G., Chiarle, R., Simmons, W. J., Piva, R., Schlessinger, K. & Levy, D. E. (2005) Cell Cycle 4, 1131-1133.
8. Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E. & Inghirami, G. (2002) Oncogene 21, 1038-1047.
9. Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E. & Inghirami, G. (2005) Nat. Med. 11, 623-629.
10. Buettner, R., Mora, L. B. & Jove, R. (2002) Clin. Cancer Res. 8, 945-954.
11. Dunn, G. P., Old, L. J. & Schreiber, R. D. (2004) Immunity 21, 137-148.
12. Gamero, A. M., Young, H. A. & Wiltrout, R. H. (2004) Cancer Cell 5, 111-112.
13. Amin, H. M., McDonnell, T. J., Ma, Y., Lin, Q., Fujio, Y., Kunisada, K., Leventaki, V., Das, P., Rassidakis, G. Z., Cutler, C., et al. (2004) Oncogene 23, 5426-5434.
14. Wan, W., Albom, M. S., Lu, L., Quail, M. R., Becknell, N. C., Weinberg, L. R., Reddy, D. R., Holskin, B. P., Angeles, T. S., Underiner, T. L., et al. (2006) Blood 107, 1617-1623.